QDA-13064-99037 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-04-03
Dose 1 — Pfizer-BioNTech
2021-04-05
Registered in v-safe
2021-04-05
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Site: Pain · None

Adult check-in
2021-04-06
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-04-07
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-04-08
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-04-24
Dose 2 — Pfizer-BioNTech
2021-04-24
Health check-in — day 0, dose 2
Feeling: Good · Site: Pain, Swelling · None

Adult check-in
2021-04-25
Survey response — days 1–6 daily, dose 2
MedDRA: Injection site bruising — Feeling: Fair · Site: Pain, Swelling · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities

Free text: Bruising at injection site, also on day 1

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-04-26
Survey response — days 1–6 daily, dose 2
MedDRA: Dry mouth, Injection site bruising, Lymph node pain, Lymphadenopathy, Thirst — Feeling: Good · Site: Pain, Swelling · Fatigue or tiredness

Free text: Dry mouth and increased thirst yesterday and today, swollen painful lymph nodes both days, bruising at injection site

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-07-24
Health check-in — 3 months, dose 2
Feeling: Good

Adult check-in
2021-10-24
Survey response — 6 months, dose 2
MedDRA: COVID-19, Cough, Oropharyngeal pain, Respiratory tract congestion — Feeling: Good

Free text: Sore throat, congestion, cough. COVID.

MedDRA releases: 2024-11 · check-in free text available
2022-01-13
Dose 3 — Moderna
2022-01-13
Health check-in — day 0, dose 3
Feeling: Fair · Site: Pain · Fatigue or tiredness

Adult check-in
2022-01-14
Survey response — days 1–6 daily, dose 3
MedDRA: Hypoaesthesia, Lymphadenopathy, Paraesthesia, Vision blurred — Feeling: Poor · Site: Pain · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activities

Free text: Injection arm: numb and tingling, swollen lymph nodes underarm; blurry vision

MedDRA releases: 2024-11 · check-in free text available
2022-01-18
Health check-in — days 1–6 daily, dose 3
Feeling: Good · None

Adult check-in

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-04-03	Pfizer-BioNTech
2	2021-04-24	Pfizer-BioNTech
3	2022-01-13	Moderna	No

Free text

Release 7 — days 1–6 daily, dose 2

2021-04-25

Systemic reaction (other): Bruising at injection site, also on day 1

Release 8 — days 1–6 daily, dose 2

2021-04-26

Systemic reaction (other): Dry mouth and increased thirst yesterday and today, swollen painful lymph nodes both days, bruising at injection site

Release 10 — 6 months, dose 2

2021-10-24

Symptoms: Sore throat, congestion, cough. COVID.

Release 10 — days 1–6 daily, dose 3

2022-01-14

Systemic reaction (other): Injection arm: numb and tingling, swollen lymph nodes underarm; blurry vision

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Cough	·	·	✓
SD	COVID-19	·	·	✓
SD	Oropharyngeal pain	·	·	✓
SD	Respiratory tract congestion	·	·	✓
SRO	Dry mouth	✓	✓	✓
SRO	Hypoaesthesia	·	·	✓
SRO	Injection site bruising	✓	✓	✓
SRO	Lymph node pain	✓	✓	✓
SRO	Lymphadenopathy	✓	✓	✓
SRO	Paraesthesia	·	·	✓
SRO	Thirst	✓	✓	✓
SRO	Vision blurred	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release